Positive effect of dapagliflozin on left ventricular longitudinal function for type 2 diabetic mellitus patients with chronic heart failure

MLA

Hidekazu Tanaka, et al. “Positive Effect of Dapagliflozin on Left Ventricular Longitudinal Function for Type 2 Diabetic Mellitus Patients with Chronic Heart Failure.” Cardiovascular Diabetology, vol. 19, no. 1, Jan. 2020, pp. 1–9. EBSCOhost, https://doi.org/10.1186/s12933-019-0985-z.

APA

Hidekazu Tanaka, Fumitaka Soga, Kazuhiro Tatsumi, Yasuhide Mochizuki, Hiroyuki Sano, Hiromi Toki, Kensuke Matsumoto, Junya Shite, Hideyuki Takaoka, Tomofumi Doi, & Ken-ichi Hirata. (2020). Positive effect of dapagliflozin on left ventricular longitudinal function for type 2 diabetic mellitus patients with chronic heart failure. Cardiovascular Diabetology, 19(1), 1–9. https://doi.org/10.1186/s12933-019-0985-z

Chicago

Hidekazu Tanaka, Fumitaka Soga, Kazuhiro Tatsumi, Yasuhide Mochizuki, Hiroyuki Sano, Hiromi Toki, Kensuke Matsumoto, et al. 2020. “Positive Effect of Dapagliflozin on Left Ventricular Longitudinal Function for Type 2 Diabetic Mellitus Patients with Chronic Heart Failure.” Cardiovascular Diabetology 19 (1): 1–9. doi:10.1186/s12933-019-0985-z.